Advertisement
Advertisement
ORMP
Oramed Pharmaceuticals Inc.
4.79
USDSponsored
+0.07
+1.48%
Sep 24, 15:59 UTC -4
Closed
Pre-Market
4.79
0.00
0.00%
Oramed Pharmaceuticals Inc. Profile
About
Info & Links
CEO
Nadav Kidron
Headquarters
NEW YORK, NY 10036, UNITED STATES
Industry
Sector
Website
Auditor
Kesselman & Kesselman
Share holders
40
Employees
13
Oramed Pharmaceuticals Inc. Statistics
Valuation Measures
Market Capitalization2
199.25M
Enterprise Value
184.01M
Enterprise Value/EBITDA(ttm)
-12.78
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
0.62
Price to Cash(ytd)
52.36
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-5.17%
Return on Invested Capital(ttm)
69.62%
Return on Assets(ttm)
-4.54%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-14.40M
Net Income Available to Common(ttm)
174.06M
Diluted EPS(ttm)
4.12
Share Statistics
Beta (5Y Monthly)
1.19
52-Week Change
99.58%
S&P 500 52-Week Change
19.38%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
41.60M
Dividend Yield
5.26%
Float4
32.96M
% Held by Insiders
20.77%
% Held by Institutions
12.73%
Balance Sheet
Total Cash(mrq)
50.61M
Total Cash Per Share(mrq)
1.22
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
4.98%
Quick Ratio(mrq)
4.98%
Book Value Per Share(mrq)
7.68
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.07
Free Cash Flow(ytd)
-3.12M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.